Predictions
National Express Group
Start price
Target price
Perf. (%)
€1.59
09.03.23
09.03.23
-
09.03.24
09.03.24
-42.77%
10.03.24
10.03.24
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.29
06.03.23
06.03.23
-
06.03.24
06.03.24
-13.18%
17.03.23
17.03.23
Risky Investment
Rolls Royce Holdings plc ADR
Start price
Target price
Perf. (%)
€1.58
27.02.23
27.02.23
-
27.02.24
27.02.24
169.62%
28.02.24
28.02.24
BAE Systems plc
Start price
Target price
Perf. (%)
€10.80
26.02.23
26.02.23
-
26.02.24
26.02.24
8.24%
16.04.23
16.04.23
Could be worthwhile Investment >10% per year
High dividend yield expected
Good rating
Revenue growth >5% per year expected
Hemogenyx Pharmaceuticals
Start price
Target price
Perf. (%)
€0.020
03.02.23
03.02.23
-
03.03.23
03.03.23
-2.56%
04.03.23
04.03.23
Could be worthwhile Investment >10% per year
British American Tobacco PLC ADR
Start price
Target price
Perf. (%)
€34.80
29.01.23
29.01.23
€50.00
01.01.26
01.01.26
9.89%
10:39
10:39
Could be very worthwhile Investment >20% year
High dividend yield expected
ITM Power plc
Start price
Target price
Perf. (%)
€1.01
23.01.23
23.01.23
€1.00
23.01.24
23.01.24
-44.87%
24.01.24
24.01.24
Known brand
Very Future proof/growth oriented business model
Growths faster than the competition
Small cyclical dependencies
Carbylan Therapeutics Inc
Start price
Target price
Perf. (%)
€6.60
03.01.23
03.01.23
€10.00
31.12.25
31.12.25
30.22%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Direct Line Insurance Grp.
Start price
Target price
Perf. (%)
€2.53
23.12.22
23.12.22
-
23.12.23
23.12.23
-24.19%
24.08.23
24.08.23
British American Tobacco PLC
Start price
Target price
Perf. (%)
€37.91
23.12.22
23.12.22
-
23.12.23
23.12.23
-20.67%
24.08.23
24.08.23
Barratt Developments plc
Start price
Target price
Perf. (%)
€4.64
22.12.22
22.12.22
-
22.12.23
22.12.23
6.90%
24.08.23
24.08.23
ITM Power plc
Start price
Target price
Perf. (%)
€1.01
20.11.22
20.11.22
€1.00
20.11.23
20.11.23
13.11%
26.11.22
26.11.22
Known brand
Very Future proof/growth oriented business model
Growths faster than the competition
Small cyclical dependencies
AstraZeneca plc
Start price
Target price
Perf. (%)
€124.30
11.11.22
11.11.22
€165.00
08.09.26
08.09.26
18.38%
12:08
12:08
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected